Evidence map›Paper›PMID 30614188›Full record

ArticleMolecular oncology2019

Hypoxia-sensitive LINC01436 is regulated by E2F6 and acts as an oncogene by targeting miR-30a-3p in non-small cell lung cancer.

Shuai Yuan, Ying Xiang, Guilu Wang, Meiyu Zhou, Gang Meng, Qingyun Liu, Zeyao Hu, Chengying Li, Weijia Xie, Na Wu and 7 more

Open access · goldAbstract read
In one paragraph

Article in Molecular oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Hypoxia-Long Noncoding RNA Interaction in Solid Cancers.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. EPAS1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial-mesenchymal transition.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Shuai YuanDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Ying XiangDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Guilu WangDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Meiyu ZhouDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Gang MengDepartment of Pathology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Qingyun LiuDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Zeyao HuDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Chengying LiDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Weijia XieDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Na WuDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Long WuDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Tongjian CaiDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Xiangyu MaDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Yao ZhangDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Zubin YuDepartment of Thoracic Surgery, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Li BaiDepartment of Respiratory Disease, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Yafei LiDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, China.
Army Medical University · CNGuiyang Medical University · CNSouthwest Hospital · CN

Funding

Chongqing Natural Science Foundation of China CSTC2015jcyBX0110Foundation for Clinical Research from Xinqiao Hospital, Third Military Medical University 2014YLC13Foundation for Clinical Research from Xinqiao Hospital, Third Military Medical University 2015YLC21National Natural Science Foundation of China 81171903National Natural Science Foundation of China 81370139National Natural Science Foundation of China 81472190National Natural Science Foundation of China 81602933National Natural Science Foundation of China 81672316
6 · The paper itself

Abstract

Dysregulation of long noncoding RNA (lncRNA) is known to be involved in numerous human diseases, including lung cancer. However, the precise biological functions of most lncRNA remain to be elucidated. Here, we identified a novel up-regulated lncRNA, LINC01436 (RefSeq: NR_110419.1), in non-small cell lung cancer (NSCLC). High expression of LINC01436 was significantly associated with poor overall survival. Notably, LINC01436 expression was transcriptionally repressed by E2F6 under normoxia, and the inhibitory effect was relieved in a hypoxic microenvironment. Gain- and loss-of-function studies revealed that LINC01436 acted as a proto-oncogene by promoting lung cancer cell growth, migration and invasion in vitro. Xenograft tumor assays in nude mice confirmed that LINC01436 promoted tumor growth and metastasis in vivo. Mechanistically, LINC01436 exerted biological functions by acting as a microRNA (miR)-30a-3p sponge to regulate the expression of its target gene EPAS1. Our findings characterize LINC01436 as a new hypoxia-sensitive lncRNA with oncogenic function in NSCLC, suggesting that LINC01436 may be a potential biomarker for prognosis and a potential target for treatment.

Indexed as

Gene Expression Regulation, NeoplasticOncogenesAnimalsBase SequenceBasic Helix-Loop-Helix ProteinsCarcinoma, Non-Small-Cell LungCell Line, TumorCell MovementCell ProliferationE2F6 Transcription FactorEndothelial PAS Domain-Containing Protein 1HumansLung NeoplasmsMaleMice, Inbred BALB CMice, NudeBasic Helix-Loop-Helix ProteinsE2F6 protein, humanE2F6 Transcription FactorEndothelial PAS Domain-Containing Protein 1MAS1 protein, humanMicroRNAsMIRN30b microRNA, humanProto-Oncogene MasRNA, Long NoncodingEPAS1hypoxiaLINC01436long noncoding RNAmicroRNA-30a-3pnon-small cell lung cancer

Identifiers

PMID30614188
PMCPMC6441908
OpenAlexW2909290372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.